Summary
A procedure for analyzing effects of drugs on distractibility is proposed. Rats are trained to traverse a straight runway with a sucrose solution as reinforcement. Once the response has been acquired, an additional runway ending in an empty box is connected. The time spent investigating this additional runway is the measure of distractibility. Amphetamine, 1 mg/kg i.p., increased distractibility. In rats that were never reinforced, amphetamine at a dose of 1 mg/kg reduced the time spent in the additional runway. This shows that the effects of amphetamine in the reinforced animals cannot be interpreted as enhanced exploration. Furthermore, the benzodiazepines diazepam (2 and 4 mg/kg, i.p.) and chlordiazepoxide (2.5, 5 and 10 mg/kg, i.p.), known to enhance exploration of novel environments, did not affect the time spent in the additional runway in sucrose-reinforced animals. It was concluded that the procedure indeed is a model of distractibility. The dopamine antagonist cis(Z)-flupenthixol, at a dose of 0.25 mg/kg, i.p., blocked the effects of amphetamine, 1 mg/kg. Flupenthixol itself, in doses of 0.25 and 0.5 mg/kg, did not affect the time spent in the additional runway. This suggests that enhanced dopaminergic activity indeed is responsible for the effects. This proposal is further supported by experiments showing that the noradrenaline precursor dihydroxyphenylserine (10 mg/kg + carbidopa, 50 mg/kg, both i.p.) and the noradrenergic neurotoxin DSP4 (50 mg/kg, i.p.) had no effect on distractibility. Moreover, amfonelic acid, a dopamine releaser with slight or no effect on noradrenergic neurotransmission, had effects very similar to those of amphetamine when given in doses of 0.25 and 0.5 mg/kg, i.p. A lower dose, 0.125 mg/ kg, was ineffective. Taken together, these data suggest that enhanced dopaminergic neurotransmission increases distractibility in the rat. However, both amphetamine and amfonelic acid may stimulate serotonin release. Until serotonergic drugs have been tested, a contribution of this transmitter cannot be ruled out. The distraction procedure may constitute an animal model of some kinds of disordered information processing.
Similar content being viewed by others
References
Ågmo A, Fernández H (1989) Dopamine and sexual behavior in the male rat: a reevaluation. J Neural Transm 77: 21–37
Ågmo A, Picker Z (1990) Catecholamines and the initiation of sexual behavior in male rats without sexual experience. Pharmacol Biochem Behav 35: 327–334
Ågmo A, Fernández H (1991) Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms. Pharmacol Biochem Behav 38: 781–788
Ågmo A, Pruneda R, Guzmán M, Gutièrrez M (1991) GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines. Naunyn Schmiedebergs Arch Pharmacol 344: 314–322
Ågmo A, Galvan A, Talamantes B (1995) Reward and reinforcement produced by drinking sucrose: two processes that may depend on different neurotransmitters. Pharmacol Biochem Behav 52: 403–414
Braff DL (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 19: 233–259
Cohen BM, Lipinski FH (1986) In vivo potencies of antispychotic drugs in blocking alpha1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life Sci 39: 2571–2580
Crider A, Solomon PR, McMahon MA (1982) Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder. Biol Psychiat 17: 351–361
Crider A, Blockel L, Solomon PR (1986) A selective attention deficit in the rat following induced dopamine receptor supersensitivity. Behav Neurosci 100: 315–319
Dunn LA, Atwater GE, Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology 112: 315–323
Edwards DJ, Sedlock ML (1982) Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine. J Pharm Pharmacol 34: 685–686
Ellenbroek BA, Cools AR (1990) Animal models with construct validity for schizophrenia. Behav Pharmacol 1: 469–490
Feldon J, Weiner I (1989) Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacol Biochem Behav 32: 123–127
Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol Psychiat 29: 636–646
Feldon J, Shofel A, Weiner I (1991) Latent inhibition is unaffected by direct acting dopamine agonists. Pharmacol Biochem Behav 38: 309–314
Franke P, Maier W, Hardt J, Hain C, Cornblatt BA (1994) Attentional abilities and measures of schizotypy: their variation and covariation in schizophrenic patients, their siblings, and normal control subjects. Psychiat Res 54: 259–272
Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14: 1–84
Harvey P, Peddley M (1989) Auditory and visual distractibility in schizophrenia. Schizophr Res 2: 295–300
Hemsley DR (1987) An experimental psychological model for schizophrenia. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 179–188
Honey RC, Hall G (1989) Attenuation of latent inhibition after compound pre-exposure: associative and perceptual explanations. Q J Exp Psych Sect B Comp Physiol Psychol 41: 355–368
Hughes RN, Greig AM (1976) Effects of caffeine, methamphetamine and methylphenidate on reactions to novelty and activity in rats. Neuropharmacology 15: 673–676
Hyttel J (1983) SCH 23390 — The first selective dopamine D-1 antagonist. Eur J Pharmacol 91: 153–154
Joseph MH, Jones SH (1991) Latent inhibition and blocking: further considerations of their construct validity as animal models of schizophrenia. Behav Pharmacol 2: 521–526
Kamin LJ (1968) “Attention-like” processes in classical conditioning. In: Jones MR (ed) Miami symposium on the prediction of behavior. University of Miami Press, Coral Gables FL, pp 9–33
Killcross AS, Robbins TW (1993) Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology 110: 479–489
Kumar R (1969) Exploration and latent learning: differential effects of dexamphetamine on components of exploratory behaviour in rats. Psychopharmacologia 16: 54–72
Kumar R (1971) Extinction of fear. I. Effects of amylobarbitone and dexamphetamine given separately and in combination on fear and exploratory behaviour in rats. Psychopharmacologia 19: 163–187
Kuczenski R, Segal DS (1994) Neurochemistry of amphetamine. In: Cho A, Segal DS (eds) Amphetamine and its analogs: psychopharmacology, toxicology and abuse. Academic Press, New York, pp 81–113
Lister RG (1990) Ethologically based animal models of anxiety disorders. Pharmacol Ther 46: 321–340
Lubow RE, Moore AU (1959) Latent inhibition. The effect of non-reinforced preexposure to the conditioned stimulus. J Comp Physiol Psychol 52: 415–419
Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I (1993) Dopamine D1 D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265: 498–508
McGaugh JL (1989) Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Res Bull 23: 339–345
Misslin R, Ropartz P (1981) Effects of metamphetamine on novelty-seeking behaviour in mice. Psychopharmacology 75: 39–43
Paredes RG, Ågmo A (1992) GABA and behavior: the role of receptor subtypes. Neurosci Biobehav Rev 16: 145–170
Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drag interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16: 549–556
Reches A, Jackson-Lewis V, Fahn S (1985) Dl-threo-DOPS as a precursor of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol 331: 202–208
Robbins T, Iversen SD (1973) A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats. Psychopharmacologia 28: 155–164
Russell PA (1983) Psychological studies of exploration in animals: a reappraisal. In: Archer J, Birke L (eds) Exploration in animals and humans. Van Nostrand Reinhold, London, pp 22–54
Solomon PR, Staton DM (1982) Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore irrelevant stimulus. Biol Psychiat 17: 743–756
Speciale Jr SG, Karoum F, Wyatt RJ (1980) Different effects of amphetamine and amfonelic acid on peripheral and central catecholamine metabolism. Eur J Pharmacol 62: 297–307
Strupp BJ, Bunsey M, Levtsky D, Kesler M (1991) Time-dependent effects of post-trial amphetamine treatment in rats: evidence for enhanced storage of representational memory. Behav Neural Biol 56: 62–76
Tombaugh TN, Tombaugh J, Anisman H (1979) Effects of dopamine receptor blockade on alimentary behaviors: home cage food consumption, operant acquisition and performance. Psychopharmacology 66: 219–225
Warburton EC, Feldon J, Weiner I, Gray JA, Joseph MH (1992) Antagonism of low dose amphetamine disruption of latent inhibition in rats by haloperidol, and by the 5-HT3 antagonist, ondansetron. J Psychopharmacol 6: 110
Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108: 442–461
Weiner I, Lubow RE, Feldon J (1981) Chronic amphetamine and latent inhibition. Behav Brain Res 2: 285–286
Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83: 194–199
Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30: 871–878
Wise RA, Colle LA (1984) Pimozide attenuates free feeding: best scores analysis reveals a motivational deficit. Psychopharmacology 84: 446–451
Wurtman RJ, Watkins CJ (1977) Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase. Nature 265: 79–80
Young PT (1959) The role of affective processes in learning and motivation. Psychol Rev 66: 104–125
Author information
Authors and Affiliations
Additional information
Parts of these data were presented at the Annual Meeting of the Mexican Physiological Society, Querétaro, Mexico, August 14–18, 1988, and at the Second International Behavioral Neuroscience Conference, Clearwater, FL, April 23–25, 1993
Rights and permissions
About this article
Cite this article
Ågmo, A., Belzung, C. & Rodríguez, C. A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABA ergic neurotransmission. J. Neural Transmission 104, 11–29 (1997). https://doi.org/10.1007/BF01271291
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271291